This bill establishes new definitions for "alternative nicotine products" and "vapor products" to include a wide range of non-tobacco items like e-cigarettes and their components, while excluding those already regulated as drugs or devices. It creates a dedicated state health care trust fund financed by taxes on these products and traditional tobacco, with a specific portion of the revenue allocated to pediatric cancer research and clinical therapy at the University of Iowa. Additionally, the legislation introduces an inventory tax for businesses holding stock of these products when tax rates increase and clarifies the roles of distributors, manufacturers, and wholesalers in the supply chain.
This bill establishes ongoing state funding for pediatric cancer research at the University of Iowa Hospitals and Clinics. Beginning in fiscal year 2026, the state will allocate one dollar per resident annually to the State Board of Regents, with a maximum cap of three million dollars per year. The funds are restricted specifically to laboratory research and clinical trials, prohibiting their use for administrative overhead or unrelated activities. Additionally, the State Board of Regents must submit an annual report to the governor and the General Assembly detailing how the money was spent.
House File 919 creates a new "specialty hospital" designation for certain nonprofit organizations in Iowa that were previously licensed nursing facilities. These hospitals must primarily serve individuals aged 30 and younger, with a high percentage of patients receiving Medicaid, and specialize in pediatric rehabilitation or complex medical/behavioral health needs.
The bill directs state departments to grant qualifying entities a provisional general hospital license by July 1, 2025, enabling them to receive enhanced hospital-based reimbursement set at their average allowable per diem costs. It also allows for waivers from certain hospital facility requirements, construction standards, and exemptions from providing specific emergency, laboratory, or pathology services beyond what they currently offer. Furthermore, the bill permits the redesignation of nursing facility beds to specialty hospital beds and expansion up to 100 beds.
HF 2310 establishes a permanent state funding stream for pediatric cancer research at the University of Iowa Hospitals and Clinics. It appropriates $1 per Iowa resident annually (based on U.S. Census population estimates), capped at $3 million per fiscal year starting July 2026, directly from the state general fund. The funds must be used exclusively for pediatric cancer research activities - including lab work and clinical trials - at the University of Iowa, with strict prohibitions against covering administrative costs or unrelated projects. The State Board of Regents is required to submit an annual report detailing how the funds were spent to the governor and legislature by October 1. This bill directly affects the University of Iowa's cancer research programs and all Iowa residents through the per-resident funding mechanism.
HF 2314 requires Iowa health insurance plans to cover diagnosis and treatment for pediatric autoimmune neuropsychiatric disorders (PANS), PANDAS (a subset of PANS), and postinfectious autoimmune encephalopathy. It mandates coverage for medically necessary treatments - like antibiotics, behavioral therapies, plasma exchange, and immunoglobulin - as recommended by a healthcare provider and aligned with established medical protocols. The law applies to individual, group, and small group health insurance plans delivered or renewed in Iowa on or after January 1, 2027, and prohibits insurers from denying coverage based on prior treatment for these conditions or unrelated health issues. This directly affects children diagnosed with these conditions and their insurance providers.
This bill (SF 2310) requires Iowa's Health and Human Services (HHS) to verify the immigration status and U.S. citizenship of applicants and recipients before approving or continuing benefits for four specific public assistance programs: SNAP (food assistance), Medicaid (healthcare), FIP (cash assistance), and CHIP (children's health insurance). It mandates using the federal "Systematic Alien Verification for Entitlements Online" (SAVE) system to check this information. The change applies to both initial eligibility determinations and ongoing eligibility reviews for these programs. The bill does not alter benefit levels or eligibility criteria beyond this verification step.
This bill requires medical examiners in Iowa to add specific questions about an infant's most recent immunizations to death investigation reports for children aged zero to three. It mandates including the date and type of the decedent's last immunization, and if multiple shots were given at once, all must be recorded. The state medical examiner must create implementing rules to follow these requirements. This change directly affects medical examiners and health investigators handling infant death cases in Iowa.
HF 2057 establishes a permanent annual funding stream for pediatric cancer research at the University of Iowa hospitals and clinics. It appropriates $1 per Iowa resident (based on U.S. Census population estimates), capped at $3 million yearly, from the state general fund. The funds must be used exclusively for pediatric cancer research - including lab work and clinical trials - prohibiting administrative costs or unrelated activities. The state board of regents must submit an annual report detailing how the funds were spent to the governor and legislature. This bill directly affects Iowa residents (through funding) and the University of Iowa's pediatric cancer research programs.
SF 63 creates an Iowa cancer research program funded by a $4 million appropriation from the state general fund for fiscal year 2025-2026. The Department of Health and Human Services will use these funds to support cancer research projects at Iowa's public colleges and universities, allocating $1.25 million each for pediatric cancer research, cancer prevention research (addressing Iowa's high cancer rates), and basic cancer research (studying cellular responses to cancer). The department will select projects through requests for proposals, prioritizing scientific merit, potential health benefits for Iowans, and inclusion of diverse expertise. Up to 5% of the funds may cover administrative costs for the program.
HF 933 establishes requirements for pediatric palliative care centers in Minnesota, directly affecting children with serious illnesses and their families. The bill mandates specific standards for facility operations, staffing, and care coordination to ensure specialized medical support. It requires centers to meet these standards to provide services for pediatric patients facing life-threatening conditions. Signed into law by the Governor on May 27, 2025, the bill creates a framework for consistent, high-quality palliative care access.
